US FDA Staff Urge Review of Abbott Laboratories Drug Risks

Bookmark and Share

Reuters -- U.S. drug reviewers have recommended additional study of delayed development reported in children of mothers who took Abbott Laboratories’ anti-seizure drug Depakote, a memo released on Friday said.

MORE ON THIS TOPIC